ARGX · Argenx SE · Metrics
$890.22
-4.55 (-0.51%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$56.27B
Shares
62.89M
Volume · Nov 5
399.88K
Avg daily vol (3M)
357.91K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
ARGX metrics
75 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$894.77
Market cap
$56.27B
Price action
20 metricsPrice change (1W)
+4.4%
Price change (30D)
+0.1%
Price change (3M)
+7.3%
Price change (6M)
+15.3%
Price change (YTD)
+10.8%
Price change (1Y)
+12.0%
Trailing year
Price change (5Y)
+181.7%
52-week high
$1,058.90
52-week low
$663.93
Change from 52-week high
-12.0%
Change from 52-week low
+40.3%
Annualized volatility
37.4%
Annualized volatility (3M)
48.9%
Beta
0.4
RSI (14D)
58.6
Price vs SMA 50
-0.5%
Price vs SMA 200
+8.8%
Avg volume (3M)
357,278
Relative volume
1.8
Average dollar volume
$327.33M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
62.89M
Valuation
12 metricsP / E (TTM)
34.2
Trailing earnings · reciprocal yield 2.9%
PEG ratio
0.6
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
11.0×
reciprocal yield 9.1%
P / book
7.0
reciprocal yield 14.4%
FCF yield
1.7%
TTM · current market cap
Buyback yield
—
P / FCF
60.4
reciprocal yield 1.7%
P / operating cash flow
60.1
reciprocal yield 1.7%
Earnings yield
2.9%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-10-22
Profitability
9 metricsGross margin
90.2%
Operating margin
30.1%
Trailing 12 months
Net margin
32.2%
Gross profit (TTM)
$4.80B
Operating profit (TTM)
$1.60B
Net income (TTM)
$1.72B
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
18.2%
Effective tax rate
1.8%
Growth
11 metricsRevenue growth YoY
+88.6%
Year over year
Net income growth YoY
+55.1%
Revenue (TTM)
$5.33B
Trailing 12 months
EPS growth YoY
+53.1%
Shares change YoY
+1.8%
Year over year · more shares
Revenue CAGR (3Y)
+112.1%
Revenue CAGR (5Y)
+130.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
20.4%
Return on assets
17.1%
Debt / equity
—
Current ratio
5.1
EBITDA (TTM)
—
Free cash flow (TTM)
$970.03M
Quick ratio
4.9
Interest coverage
392.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$3.58B
Total assets
$10.03B
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$974.19M
Capital expenditures (TTM)
$4.17M
R&D (TTM)
$1.65B
SG&A (TTM)
—
Stock compensation (TTM)
$254.08M
R&D / revenue
31.0%
Stock compensation / revenue
4.8%
Ownership (13F)
9 metrics13F filers
514
13F filer change QoQ
+31
Institutional ownership
45.5%
Conviction holders (share of 13F filers)
2.5%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-2.3%
Holder tenure
19.8
Price vs estimated holder cost
+31.1%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.9%
Short interest
3 metricsShort interest
2.2%
Latest settlement · 2.5 days to cover
Days to cover
2.5d
Short-squeeze score
47 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1697862
CUSIP
04016X101
13F (30d)
256 filings
222 filers
Visit website
Investor relations